Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Benjamin D Hopkins¹, Chantal Pauli^{2

3}, Xing Du⁴, Diana G Wang^{1

5}, Xiang Li⁶, David Wu¹, Solomon C Amadiume¹, Marcus D Goncalves^{1

7}, Cindy Hodakoski¹, Mark R Lundquist¹, Rohan Bareja^{1

3

8}, Yan Ma⁴, Emily M Harris⁴, Andrea Sboner^{1

3

8

9}, Himisha Beltran^{1

3

10}, Mark A Rubin^{3

11}, Siddhartha Mukherjee¹², Lewis C Cantley¹³

Affiliations

¹ Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
² Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
³ Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY, USA.
⁴ Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA.
⁵ Weill Cornell Medicine/Rockefeller University/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
⁶ Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
⁷ Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
⁸ Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
⁹ Department of Pathology, Weill Cornell Medicine, New York, NY, USA.
¹⁰ Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
¹¹ Department of Biomedical Research and the Center for Precision Medicine, , University of Bern and the Inselspital, Bern, Switzerland.
¹² Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA. sm3252@cumc.columbia.edu.
¹³ Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. lcantley@med.cornell.edu.

Published Erratum

Benjamin D Hopkins et al. Nature. 2018 Nov.

. 2018 Nov;563(7731):E24.

doi: 10.1038/s41586-018-0506-3.

¹ Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
² Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
³ Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY, USA.
⁴ Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA.
⁵ Weill Cornell Medicine/Rockefeller University/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
⁶ Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
⁷ Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
⁸ Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
⁹ Department of Pathology, Weill Cornell Medicine, New York, NY, USA.
¹⁰ Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
¹¹ Department of Biomedical Research and the Center for Precision Medicine, , University of Bern and the Inselspital, Bern, Switzerland.
¹² Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA. sm3252@cumc.columbia.edu.
¹³ Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. lcantley@med.cornell.edu.

Abstract

In this Letter, author Xing Du was incorrectly listed as Du Xing; this has been corrected online.

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.
Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR, Bareja R, Ma Y, Harris EM, Sboner A, Beltran H, Rubin MA, Mukherjee S, Cantley LC. Hopkins BD, et al. Nature. 2018 Aug;560(7719):499-503. doi: 10.1038/s41586-018-0343-4. Epub 2018 Jul 4. Nature. 2018. PMID: 30051890 Free PMC article.